Enjoy complimentary customisation on priority with our Enterprise License!
The women's health therapeutics market share is expected to increase by USD 30.35 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 5.74%.
This women's health therapeutics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers women's health therapeutics market segmentation by type (fertility, oncology, menopause, infection, and others) and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The women's health therapeutics market report also offers information on several market vendors, including Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GLS Pharma Pvt. Ltd., ICON plc, Merck KGaA, Novartis AG, Novo Nordisk AS, ObsEva SA, Pfizer Inc., Radius Health Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., TSUMURA and Co., Vivesto AB, and Mithra Pharmaceuticals SA among others.
Download Report Sample to Unlock the Women's Health Therapeutics Market Size for the Forecast Period and Other Important Statistics
The strategic alliances are notably driving the women's health therapeutics market growth, although factors such as side effects of approved drugs may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the women's health therapeutics industry. The holistic analysis of the drivers will help deduce end goals and refine marketing strategies to gain a competitive edge.
Key Women's Health Therapeutics Market Driver
Strategic alliances is one of the major driver impacting the women's health therapeutics market growth. The global women's health therapeutics market has witnessed multiple strategic alliances between vendors in recent years. The drug development process requires a highly advanced R&D team, which most mid-sized and small pharmaceutical vendors lack. Similarly, these small- and mid-sized pharmaceutical vendors have low profitability, as they do not often achieve economies of scale. Similarly, the lack of an established distribution network globally poses a threat to some vendors, which is limiting their geographical presence in the market. As a result, multiple vendors in the market are entering into collaborative agreements to overcome the challenges associated with the research, manufacturing, and commercialization of drugs in new regions. Hence, increasing alliances are expected to help in overcoming the research and commercialization challenges that currently exist, thereby making the treatment reach a large patient population. Hence, the increasing number of strategic alliances is expected to contribute significantly to the growth of the global women's health therapeutics market during the forecast period.
Key Women's Health Therapeutics Market Trend
Rising awareness of gynecological diseases is one of the major trends influencing the women's health therapeutics market growth. Multiple organizations are striving to increase awareness among people about gynecological diseases such as cancer, maternity disorders, and infectious diseases. For instance, the Centers for Disease Control and Prevention (CDC) conducts a campaign called Inside Knowledge: Get the Facts About Gynecologic Cancer, which provides the public with access to information about gynecological cancers. Worldwide events such as Ovarian Cancer Awareness Month and Uterine Cancer Awareness Month conducted in September also aim to raise awareness about these diseases. Likewise, the Foundation for Women Cancer in the US observes September as Gynecologic Cancer Awareness Month every year. Moreover, some organizations work toward increasing patient awareness regarding all the major sub-types of gynecological disorders. The American Cancer Society also works to promote awareness of cancers such as cervical cancer and encourages women to get tested for cervical cancer. Such rising awareness of gynecological diseases is anticipated to drive the growth of the global women's therapeutics market during the forecast period.
Key Women's Health Therapeutics Market Challenge
Side effects of approved drugs are one of the major challenges impeding the women's health therapeutics market growth. Chemotherapy has harmful side effects as it involves the use of cytotoxic drugs to destroy cancer cells. Cytotoxic drugs cannot distinguish between healthy and cancerous cells, because of which they also destroy the healthy peripheral cells that surround the cancer cells. The destruction of normal healthy cells leads to cytotoxic side effects. Some most common side effects encountered with chemotherapy are alopecia, fatigue, myelosuppression, neurotoxicity, gastrointestinal toxicity, cutaneous reactions, reduced libido, and fertility problems. Side effects such as myelosuppression result in anemia, thrombocytopenia, neutropenia, and arthralgia, which, in turn, require additional therapies. For instance, neutropenia is known to occur in patients treated with certain cytotoxic drug regimens. These patients require infusions of granulocyte colony-stimulating factors until the white blood cells have fully recovered. Hence, to avoid such harmful side effects, patients are opting for substitutes such as debulking surgery, thereby restricting the growth of the market. Hence, the serious side effects caused by the approved drugs are expected to limit the growth of the women's health therapeutics market during the forecast period.
This women's health therapeutics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global women's health therapeutics market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the women's health therapeutics market during the forecast period.
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
This statistical study of the women's health therapeutics market encompasses successful business strategies deployed by the key vendors. The women's health therapeutics market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.
To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The women's health therapeutics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the women's health therapeutics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.